Home/Filings/4/0001415889-24-026701
4//SEC Filing

Wang Junyuan Jerry 4

Accession 0001415889-24-026701

CIK 0001811063other

Filed

Nov 12, 7:00 PM ET

Accepted

Nov 13, 4:28 PM ET

Size

6.0 KB

Accession

0001415889-24-026701

Insider Transaction Report

Form 4
Period: 2024-11-11
Wang Junyuan Jerry
DirectorCEO, ANHEART THERAPEUTICS LTD.
Transactions
  • Sale

    Class A Common Stock

    2024-11-11$2.89/sh56,361$162,8833,866,228 total
Holdings
  • Class A Common Stock

    (indirect: By LLC)
    2,246,458
Footnotes (2)
  • [F1]The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of performance-based restricted stock units. The sales were to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary transactions by the Reporting Person.
  • [F2]Shares are held directly by WangWang, LLC, of which the Reporting Person is Manager.

Issuer

Nuvation Bio Inc.

CIK 0001811063

Entity typeother

Related Parties

1
  • filerCIK 0002017749

Filing Metadata

Form type
4
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 4:28 PM ET
Size
6.0 KB